Denkert, Carsten <br/><br/>
Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy.  [electronic resource] 

 -  The Lancet. Oncology  01 2018 
 - 40-50 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1474-5488 
<br/><br/><label>Standard No.: </label>10.1016/S1470-2045(17)30904-X  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Biomarkers, Tumor--analysis<br/>Breast Neoplasms--chemistry<br/>Chemotherapy, Adjuvant<br/>Disease-Free Survival<br/>Female<br/>Humans<br/>Lymphocytes, Tumor-Infiltrating--drug effects<br/>Middle Aged<br/>Neoadjuvant Therapy--adverse effects<br/>Randomized Controlled Trials as Topic<br/>Receptor, ErbB-2--analysis<br/>Risk Factors<br/>Time Factors<br/>Treatment Outcome<br/>Triple Negative Breast Neoplasms--chemistry